Last reviewed · How we verify

NCT06593275

Pain Perception in Protection of the Palatal Donor Area After Harvesting a Free Gingival Graft Using Flowable Resin Versus a Self-adhesive Dressing

Not yet recruiting NA Last updated 10 October 2024
What this trial tests

NA trial testing Protection of the palatal donor area with flowable resin in Perception of Pain in 30 participants. Not yet recruiting.

Timeline
30 October 2024
Primary endpoint
15 December 2024
15 December 2029

Quick facts

Lead sponsorUniversidad de Especialidades Espiritu Santo
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date30 October 2024
Primary completion15 December 2024
Estimated completion15 December 2029
Sites1 location across Ecuador

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Especialidades Espiritu Santo

Who can join

18 and older, any sex, with Perception of Pain or Protection of the Palate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of a connective tissue graft harvested from the palate is currently one of the most effective and predictable alternatives for the correction of periodontal and peri-implant defects, but the discomfort generated in the palate is sometimes greater than mucogingival surgery. For this reason, we found the need to use different materials for palatal protection. In one group we will use light-cured fluid resin compared to another group a self-adhesive dressing to check which of these materials provides less postoperative pain generated by the harvest of a free gingival graft.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Universidad de Especialidades Espiritu Santo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06593275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing